Abiomed Recovering Hearts. Saving Lives
Our Company Investors News Products Clinicians Patients & Families

Press Releases
Articles
Archives

Press Contact:
Liza Heapes
Ph: 978-646-1668
Email: lheapes@abiomed.com

 
Leaders from GE Healthcare Join to Focus on Commercial Growth and Process Improvement

DANVERS, Mass, June 16, 2004 -- ABIOMED, Inc., (NASDAQ:ABMD) today announced that the Company has added three individuals to its management team.

Javier Jimenez is joining ABIOMED as Vice President of Operations. He is overseeing purchasing and materials, information technology, financial planning and budgeting. Raymond Kelley is Vice President of Corporate Marketing, responsible for the development of marketing programs to drive awareness, sales and product development. Christopher Macdonald, Senior Vice President of Global Sales, Applications and Service, is responsible for the oversight of all distribution-related functions to accelerate the integration of ABIOMED's global commercial business. All three come from positions of leadership within GE Healthcare and are certified as experts in Six Sigma management processes. Collectively, they have broad experience in finance, operations, marketing, sales, clinical applications and customer service.

"It is with great pleasure that I welcome Javier, Ray and Chris to our team. Their talents will complement the capabilities of our existing management team, helping us improve processes in order to meet our ambitious plans for growth," said Michael R. Minogue, President and CEO of ABIOMED. "I am honored that these leaders from one of world's foremost companies have chosen to join us and be a part of our incredible mission."

In addition to these changes, other positions within management have been refocused. Vice President Tony Bailey has assumed the role of Vice President of Manufacturing and is responsible for improving efficiency and accelerating production as the company prepares for increased product sales in FY '05. Gene Rabe, Vice President of US Sales, will continue to lead the US Sales team, which ABIOMED intends to expand this year.

Javier Jimenez
Javier Jimenez has extensive experience in controllership, commercial finance, and overall business operations. He was most recently Director of Commercial Operations for GE Healthcare Information Technologies Americas overseeing the sales operations of over $1B in revenues. This latest position was one of several at GE Healthcare with increasing leadership roles in finance and operations, including positions in risk management, finance management and financial planning and analysis. Javier first joined General Electric as a member of the Corporate Audit Staff, where he spent over two years performing financial audits and process reviews at several business units in the USA and Europe. During his tenure at GE he achieved Six Sigma Black Belt certification. At ABIOMED, he is responsible for operations, planning and budgeting, and information systems.

Mr. Jimenez started his professional career in technical sales in Spain. He holds BS and MS degrees in Aeronautical Engineering from Universidad Politécnica in Madrid, Spain, and earned his MBA from Boston University.

Raymond Kelley
Raymond Kelley is joining ABIOMED following a career at GE Healthcare where he held numerous roles in sales, marketing and product development, including the Americas Marketing Manager position for the $650M Hi-Field Magnetic Resonance (MR) business. Under this program, he successfully formulated pricing strategy, maximized margins and increased sales volume through effective training, marketing and product launches. Mr. Kelley also made important contributions as lead engineer in the development of intra-operative Neuro-surgical MR procedures and technologies, working closely with surgeons in the operating rooms of the world's leading medical centers.

Most recently, Ray held the MR Sales Specialist position for the New Jersey and Baltimore region. He significantly grew orders and sales within these regions and increased market share through effective regional marketing and installed base programs. Prior to the marketing position, Mr. Kelley drove intranet and internet awareness programs as a Global eBusiness leader. During his tenure at GE Healthcare, he earned Six Sigma Black Belt certification. Prior to joining GE, he worked as a research engineer at Brigham and Women's Hospital in Boston.

Mr. Kelley earned a Bachelor of Science degree in Electrical Engineering from Northeastern University, and has been awarded numerous professional honors.

Christopher Macdonald
Mr. Macdonald joins ABIOMED following a career at GE Healthcare. Most recently he was the central U. S. Cardiology Zone Manager where he set consistent number one performance records for orders and sales revenue in excess of $100M. Prior to holding that position, Mr. Macdonald was the Corporate Accounts Director for Americas Cardiology and led the commercial Six Sigma quality team for the Information Technologies Business Unit. He also served as the Operations Manager for GE Cardiology with annual revenues in excess of $200M. Chris is certified as a Master Black Belt in Statistics of Six Sigma. His GE leadership appointments followed a very successful 6-year track record in both cardiology and information technology sales with Marquette Medical Systems.

Mr. Macdonald graduated with a Bachelor of Science degree in Biology from Tulane University.

Based in Danvers, Massachusetts, ABIOMED, Inc. (pronounced “AB’-EE-O-MED”) is a leading developer, manufacturer and marketer of medical products designed to assist or replace the pumping function of the failing heart. ABIOMED currently manufactures and sells the AB5000™ Circulatory Support System and the BVS® 5000 Biventricular Support System for the temporary support of all patients with failing but potentially recoverable hearts. The Company’s AbioCor® Implantable Replacement Heart is the subject of an initial clinical trial being conducted under an Investigational Device Exemption from the United States Food and Drug Administration. The AbioCor has not been approved for commercial distribution, and is not available for use or sale outside of the initial clinical trial.

###

Media Contact:
Andrea tenBroek
Communications Specialist
(978) 646-1419
mediarelations@abiomed.com

Investor Relations Contact:
Edward E. Berger, Ph.D.
Vice President for Policy, Reimbursement and External Relations
(978) 646-1411
ir@abiomed.com